Zantac, Ranitidine Pulled From Market, Here Are FDA ’s Latest Cancer Concerns

New findings about N-Nitrosodimethylamine (NDMA) contamination of this type of heartburn medication led to the U.S. Food and Drug Administration ' s (FDA ' s) more drastic action.

Source: Forbes.com Healthcare News - April 2, 2020 Category: Pharmaceuticals Authors: Bruce Y. Lee, Contributor Source Type: news